Publications

Detailed Information

Soluble pig lymphocyte activation gene-3 (LAG-3; CD223) inhibits human-to-pig xenogeneic mixed lymphocyte reaction

DC Field Value Language
dc.contributor.authorKim, Seon-Soo-
dc.contributor.authorByun, Hyun-Jung-
dc.contributor.authorKim, Sang-Hoon-
dc.contributor.authorLee, Han-Hyoung-
dc.contributor.authorKim, Sang Joon-
dc.contributor.authorChun, Taehoon-
dc.contributor.authorPark, Chung-Gyu-
dc.contributor.authorLee, Suk Jun-
dc.date.accessioned2012-06-11T02:07:27Z-
dc.date.available2012-06-11T02:07:27Z-
dc.date.issued2010-02-
dc.identifier.citationBIOTECHNOLOGY LETTERS; Vol.32 2; 203-208ko_KR
dc.identifier.issn0141-5492-
dc.identifier.urihttps://hdl.handle.net/10371/76941-
dc.description.abstractLymphocyte activation gene-3 (LAG-3; CD223) is a transmembrane protein that is structurally similar to CD4. Since LAG-3 has a much higher binding affinity to MHC class II than that of CD4, several approaches using soluble LAG-3 were used to modulate immune responses by activation or inhibition of MHC class II expressing antigen presenting cells. In this study, we constructed soluble pig LAG-3 containing a critical binding site (D1 and D2 region) to MHC class II molecules, combined with a constant region of an immunoglobulin (Ig) heavy chain. Flow cytometry analyses indicated that soluble pig LAG-3 binds to both pig and human MHC class II molecules. Moreover, soluble pig LAG-3 can inhibit human lymphocyte proliferation in the human-pig xenogeneic mixed lymphocyte reaction in a dose-dependent manner. These results indicate that soluble pig LAG-3 may be useful for controlling the xenogeneic T cell immune responses between the human and pig.ko_KR
dc.language.isoenko_KR
dc.publisherSPRINGERko_KR
dc.subjectCo-receptorko_KR
dc.subjectLymphocyte activation gene-3ko_KR
dc.subjectMixed lymphocyte reactionko_KR
dc.subjectXenogeneic responseko_KR
dc.subjectT cell activationko_KR
dc.subjectPigko_KR
dc.titleSoluble pig lymphocyte activation gene-3 (LAG-3; CD223) inhibits human-to-pig xenogeneic mixed lymphocyte reactionko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor김선수-
dc.contributor.AlternativeAuthor변현정-
dc.contributor.AlternativeAuthor김상훈-
dc.contributor.AlternativeAuthor이한형-
dc.contributor.AlternativeAuthor이석준-
dc.contributor.AlternativeAuthor김상준-
dc.contributor.AlternativeAuthor박청규-
dc.contributor.AlternativeAuthor전태훈-
dc.identifier.doi10.1007/s10529-009-0144-9-
dc.citation.journaltitleBIOTECHNOLOGY LETTERS-
dc.description.citedreferenceSprangers B, 2008, KIDNEY INT, V74, P14, DOI 10.1038/ki.2008.135-
dc.description.citedreferenceFougeray S, 2006, VACCINE, V24, P5426, DOI 10.1016/j.vaccine.2006.03.050-
dc.description.citedreferenceBuisson S, 2005, IMMUNOLOGY, V114, P369, DOI 10.1111/j.1365-2567.2004.02087.x-
dc.description.citedreferenceDi Carlo E, 2005, J PATHOL, V205, P82, DOI 10.1002/path.1679-
dc.description.citedreferenceChun T, 2004, BIOTECHNOL LETT, V26, P1371-
dc.description.citedreferenceAndreae S, 2003, BLOOD, V102, P2130-
dc.description.citedreferenceLai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228-
dc.description.citedreferenceNiemann H, 2001, TRANSPLANTATION, V72, P1898-
dc.description.citedreferenceSUBRAMANYAM M, 1998, INT IMMUNOL, V20, P679-
dc.description.citedreferenceKobayashi T, 1997, TRANSPLANTATION, V64, P1255-
dc.description.citedreferenceHuard B, 1997, P NATL ACAD SCI USA, V94, P5744-
dc.description.citedreferenceOry DS, 1996, P NATL ACAD SCI USA, V93, P11400-
dc.description.citedreferenceHUARD B, 1994, EUR J IMMUNOL, V24, P3216-
dc.description.citedreferenceTRIEBEL F, 1990, J EXP MED, V1711, P393-
dc.description.tc2-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share